Boothbay Fund Management, LLC Summit Therapeutics Inc. Transaction History

Boothbay Fund Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$2.55 - $5.07 $12,750 - $25,350	5,000 Added 16.67%	35,000 $144,000
Q2 2023 Aug 14, 2023	SELL	$1.32 - $2.81 $167,633 - $356,855	-126,995 Reduced 80.89%	30,000 $75,000
Q1 2023 May 15, 2023	SELL	$1.38 - $5.41 $88,609 - $347,376	-64,210 Reduced 29.03%	156,995 $274,000
Q4 2022 Feb 14, 2023	BUY	$0.68 - $5.31 $150,419 - $1.17 Million	221,205 New	221,205 $940,000
Q2 2022 Aug 15, 2022	SELL	$0.92 - $2.38 $67,519 - $174,670	-73,391 Reduced 47.36%	81,559 $82,000
Q1 2022 May 16, 2022	BUY	$2.0 - $3.45 $309,900 - $534,577	154,950 New	154,950 $380,000

192

75.8M

2.01M

2.84M

Ticker SMMT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,215,008
Market Cap $3.6B
Description
Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.